Two cyclic nucleotide phosphodiesterase (PDE) activities were identified in pig aortic endothelial cells, a cyclic GMP-stimulated PDE and a cyclic AMP PDE. Cyclic GMP-stimulated PDE had Km values of 367 ,UM for cyclic AMP and 24 /M for cyclic GMP, and low concentrations (1 #M) of cyclic GMP increased the affinity of the enzyme for cyclic AMP (Km = 13 #M) without changing the V.ax.. Dipyridamole enhanced the increase in cyclic GMP induced by sodium nitroprusside. Cyclic AMP accumulation was stimulated by dipyridamole and trequinsin with and without forskolin. Rolipram, although without effect alone, increased cyclic AMP in the presence of forskolin, whereas M&B 22948 and SK&F 94120 had no effects on resting or forskolin-stimulated levels. These results suggest that cyclic GMPstimulated PDE regulates cyclic GMP levels and that both endothelial PDE isoenzymes contribute to the control of cyclic AMP.
INTRODUCTION
The cyclic nucleotide cascades of endothelial cells are targets for a number of endogenous substances which may modify endothelial function. Endothelium-derived relaxing factor (EDRF) and atrial natriuretic factors increase cyclic GMP synthesis through activation of the soluble and particulate guanylate cyclases, respectively (Martin et al., 1988) . Activation of the cyclic AMP cascade has also been demonstrated in intact cells, and a number of substances, including adenosine and calcitonin-gene-related peptide, stimulate adenylate cylase in isolated endothelial-cell membrane preparations (Dembinska-Kiec et al., 1980; Makarski, 1981 ; Goldman et al., 1983; Crossman et al., 1987) .
Little is known of the processes in endothelial cells responsible for the catabolism of cyclic AMP and cyclic GMP. In the studies reported herein, we have partially purified the phosphodiesterases (PDEs) 9, 4, 6, isoquinolin-4-one) was supplied by Hoechst Pharmaceuticals (Hounslow, Middx., U.K.). The endothelial cells were cultured by a modification of the method previously described by Martin et al. (1988) . The cells grew as a strict monolayer and exhibited the characteristic 'cobblestone' appearance. In randomly selected cultures, over 95 % of the cells were observed to fluoresce after incubation with acetylated low-density lipoprotein labelled with 1,1'-dioctadecyl-1,3,3',3'-tetramethylindocarbocyanine perchlorate (Voyta et al., 1984) . Partial purification of endothelial-celi PDEs Cells (100-150 million) grown in 250 ml culture flasks (Nunclon) were washed three times with phosphatebuffered saline (Dulbecco & Vogt, 1954) before being scraped from the surface and removed to a 50 ml polypropylene centrifuge tube. The cells were then centrifuged (2000 g, 5 min) and, after the phosphate-buffered saline had been removed, the pellet was stored at -70°C until required.
The cell pellet was homogenized in 6 vol. of 20 mMTris/HCl (pH 7.5) containing 2 mM-magnesium acetate, 1 mM-dithiothreitol, 5 mM-EDTA and 2000 units of aprotinin/ml with a Dounce homogenizer. The homogenate was then centrifuged at 105 000 g for 60 min and the supernatant (20 ml) applied to a DEAE-Trisacryl column (7 cm x 0.9 cm) pre-equilibrated with column buffer (20 mM-Tris/HCl, 2 mM-magnesium acetate, 1 mMdithiothreitol, 20 IM-]Na-tosyl-L-lysylchloromethane hydrochloride, pH 7.5). The column was washed with 50 ml of column buffer, and PDE activities were eluted with two successive linear gradients ofNaCl (0-150 mm in 80 ml and 150-400 mm in 70 ml) in column buffer; 2 ml fractions were collected, assayed, and for short-term storage at -20°C, ethylene glycol was added to a final concentration of 30 % (v/v). Assays on the pooled peak fractions were performed within 48 h after homogenization of the cells. Measurement of PDE activity PDE activity was determined by the two-step radioisotope method of Thompson et al. (1979) Protein was determined as described by Lowry et al. (1951) , with bovine serum albumin as the standard.
Categorization of PDE isoenzymes
The nomenclature for the different cyclic nucleotide PDEs adopted in this paper is based on that of Beavo (1988) and Torphy (1988) .
Measurement of cyclic nucleotides
Cyclic nucleotide studies were performed as previously described (Martin et al., 1988) . Drugs were added to the cells at the concentrations and times indicated in the Results section. The DNA content of the cell pellets was measured by an automated procedure employing the fluorochrome Hoechst 33258 (Sterzel et al., 1985) .
Statistical analysis
Data are presented as means + S.E.M. and analysed by Student's t test or, where stated, the Mann-Whitney test. Values were considered to be statistically significant when P was less than 0.05.
RESULTS

Endothelial-cell cyclic nucleotide PDEs
The present studies demonstrated the presence of two PDE isoenzymes in pig aortic endothelial cells, a cyclic GMP-stimulated isoform and a cyclic AMP PDE exhibiting properties similar to those of the Type IV PDE identified in cardiac muscle by Reeves et al. (1987) .
The cytosolic fraction of pig aortic endothelial cells contained 58 % of the cyclic GMP hydrolytic activity (assayed at 1 /M substrate concentration) and 58 % of the cyclic AMP hydrolytic activity (assayed at 2 /tM substrate concentration) ( Table 1) . Addition of Ca2+/ calmodulin had no effect on either cyclic GMP or cyclic AMP hydrolysis in the particulate and soluble fractions, indicating that the calmodulin-stimulated (Type 1 b) PDE is absent in endothelial cells (Table 1) . Addition of cyclic GMP (1 #M) to the cytosol and pellet increased cyclic AMP hydrolysis (2 fM substrate concn.) approx. 2-fold and did not alter the percentage of total cyclic AMP PDE activity associated with each fraction (Table 2) .
Two peaks of cytosolic PDE activity were resolved by DEAE-Trisacryl ion-exchange chromatography (Fig. 1) . The first peak, eluted at 0.12 M-NaCl, exhibited activity against both cyclic GMP and cyclic AMP, and addition of I /tM-cyclic GMP stimulated cyclic AMP hydrolysis (measured with 2 /M substrate) 4-fold. The second peak of activity was eluted with 0.19 M-NaCl and selectively hydrolysed cyclic AMP, displaying little or no activity against cyclic GMP. Over 900 of cyclic GMP PDE and cyclic AMP PDE activities applied to the DEAETrisacry' column were recovered after elution with the NaCl gradient. Kinetic Ca2l-independent cyclic GMP PDEs (Types lb and la respectively) in smooth muscle (Lugnier et al., 1986) (Waldman & Murad, 1987) (Table 6 ).
The effects of PDE inhibitors on cyclic AMP levels were tested with and without the activator of adenylate cyclase, forskolin (Table 7) . Dipyridamole (100 ,UM) and trequinsin (10 ftM) both significantly increased resting cyclic AMP (520 and 100 % respectively) and increased accumulation in the presence of 10 /uM-forskolin (1790% and 2460% respectively), which, alone, elicited a slight but non-significant effect. Rolipram (50 /M) had no effect alone, but significantly increased cyclic AMP accumulation in the presence of forskolin (72 %O). Neither M&B 22948 nor SK&F 94120 significantly influenced cyclic AMP levels in either the absence or the presence of forskolin. As with cyclic GMP, endothelial cells extruded cyclic AMP into the extracellular medium. This leakage was increased by PDE inhibitors that elevated intracellular cyclic AMP levels (results not shown). (n = 4); **P < 0.01 for significant differences from control. 
DISCUSSION
The important regulatory role which the vascular endothelium plays as an interface between blood and extravascular tissue, controlling interactions between leucocytes and the vessel wall, vascular tone, coagulation and passage of fluids, proteins and cells into and out of blood vessels has only recently been appreciated. The role of cyclic nucleotides in these processes is unclear, but the coupling of endothelial receptors to both the cyclic AMP and cyclic GMP cascades indicates that they serve a second-messenger role. Indeed, preliminary observations suggest that permeability (Stelzner et al., 1988; Mizuno-Yagyu et al., 1987) and release of humoral agents (Doni et al., 1988; Shimokawa et al., 1988) are under the influence of cyclic nucleotides. The demonstration of two cyclic nucleotide PDEs in pig aortic endothelial cells (Fig. 1) suggests that the degradation of cyclic AMP and cyclic GMP is sensitively controlled, lending further weight to the contention that they serve an important regulatory function.
Previous studies (Lugnier & Schini, 1988 ) also demonstrated the presence of a rolipram-inhibited cyclic AMP PDE and a cyclic GMP-stimulated PDE in bovine aortic endothelial cells. This latter isoenzyme comprised only a small percentage of the total activity and, curiously, was only detected in 50 % of the endothelial-cell cytosolic preparations. In contrast, in our pig aortic endothelial cell-free extracts, cyclic GMP-stimulated PDE accounted for all the cyclic GMP-hydrolytic activity and, in the presence of 1 ,#M-cyclic GMP, well over 500 of the total cyclic AMP-hydrolytic activity. The presence of the cyclic GMP-stimulated PDE suggests that elevation of cyclic GMP could decrease cyclic AMP concentrations in endothelial cells and, consequently, that these two cyclic nucleotides would have opposing effects. Evidence for this has been obtained in fibroblasts where the decrease in the content of cyclic AMP in response to atrial natriuretic factors has been ascribed to activation of PDE (Lee et al., 1988) . Thus far, we have been unable to demonstrate a decrease in endothelial cyclic AMP levels with agents that stimulate cyclic GMP accumulation (results not shown).
Data presented herein suggest that cyclic GMP-stimulated PDE plays a predominant role in regulating endothelial cyclic GMP: it is the only endothelial PDE which hydrolyses cyclic GMP ( Fig. 1) and, furthermore, non-selective PDE inhibitors induced a large increase (> 10-fold) in cyclic GMP, whereas rolipram, a selective inhibitor of Type IV cyclic AMP PDE, was without significant effect (Table 4) . The sizes of the responses to dipyridamole and trequinsin suggest a rapid intracellular turnover of cyclic GMP, with synthesis being dependent on activation of soluble guanylate cyclase by EDRF, as demonstrated by the complete abolition of the effects of the PDE inhibitors by LY-83583 (Table 5) , Methylene Blue and haemoglobin (results not shown). That PDE inhibitors potentiate the actions of stimulants of soluble guanylate cyclase is reinforced by the enhancement of the sodium nitroprusside-induced rise in cyclic GMP by dipyridamole (Table 6) .
Neither calmodulin-independent cyclic GMP PDE (Type la) nor calmodulin-dependent PDE (Type lb) reside in pig aortic endothelial cells. Not surprisingly, M&B 22948, a selective cyclic GMP PDE inhibitor (Lugnier et al., 1986) exerted no influence on cyclic GMP levels (Table 4) . This later result contrasts with previous reports (Martin et al., 1988) in which slightly elevated cyclic GMP levels were observed in response to this compound; however, in that study, higher concentrations (Table 7 ). The contribution of cyclic GMP-stimulated PDE to cyclic AMP metabolism is uncertain; however, involvement is suggested, since nonselective PDE inhibitors increased cyclic AMP in the absence of forskolin, whereas, under these conditions, rolipram was ineffective.
In conclusion, pig aortic endothelial cells contain two major cyclic nucleotide PDE species, a cyclic AMPspecific PDE and a cyclic GMP-stimulated PDE. Cyclic GMP-stimulated PDE plays a dominant role in regulating intracellular cyclic GMP, whereas both isoenzymes are probably involved in controlling cyclic AMP levels.
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